6
Total investments
3
Early stage
2
Mid stage
0
Late stage
12y
Years active
Portfolio
5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Apr 2018
Groopit: The AI Problem-Solving Engine. Groopit combines real-time intelligence from employees to solve critical business problems that impact revenue, customer satisfaction, product, competition, operations, and more.
S
Investor
Mar 2018
Cell preservation today for the personalized therapies and diagnostics of tomorrow. Silene Biotech offers consumers affordable, accessible personalized cell preservation using protocols and standards meeting current Good Manufacturing Processes as established by the FDA.
Investor
Mar 2018
QDTI is leveraging this versatile NV magnetic imaging technology to create a novel, ultrasensitive biomaterial detection, and diagnostics platform.
Investor
Jan 2018
At Decisions, our goal is to make meetings the most productive part of the day.
Our award-winning app empowers workplace leaders to maximize every meeting run with Microsoft Teams and 365, whether they’re remote, in-person or hybrid.
Decisions has helped turn millions of minutes spent in project meetings, leadership meetings, and everything in between, into more fruitful outcomes, impacting organization-wide culture changes at Fortune 500s, 10-person nonprofits, and beyond.
Download Decisions for Microsoft Teams today at: https://appsource.microsoft.com/en-US/product/office/wa104381880?mktcmpid=description_lk&src=linkedin
Investor
Jan 2014
Wellpepper is a clinically-validated platform for digital patient treatment plans. With Wellpepper health systems can deliver actionable and highly-engaging task-based treatment plans based on their own protocols and personalized for each patient. Wellpepper patients are over 70% engaged with their treatment plans. Wellpepper is used at major health systems for orthopedics, neurology, chronic disease management, rehabilitation, and many other scenarios. Wellpepper is a 2015 winner of the Mayo Clinic ThinkBig Innovation challenge, 2015 HIMSS Venture+ Forum, and 2017 Seattle Business Magazine Leaders in Healthcare.
Experience · 11 entries
All (11)
Investments (6)
Board (1)
2026
Venture Partner
Jun 2026
Gardar is Norwegian VC firm investing in battletested Ukrainian defence tech startups. We invest from seed to series B.
2021
Board Member
Oct 2021
Pragmatic is revolutionising semiconductor technology with ultra-low-cost, flexible integrated circuit (FlexIC) technology that makes it quick and easy to embed intelligence almost anywhere.
#pragmaticsemiconductor #flexics
2019
Principal
Nov 2019
Founded in 2016, Summa Equity is an investment firm focusing on the thematic areas of Circularity, Energy Transition, Sustainable Food, and Tech-Enabled Resilience. The mission of Summa is to invest in solving global challenges.
Summa has raised c. EUR 4 billion and made over 30 platform investments across the three funds raised to date. The investments address the challenges we need to solve as a society, enabling the potential for long-term sustainable outperformance.
The team is located globally, with offices in Stockholm, Oslo, Munich, and the U.S. Partnerships are part of Summa’s DNA, exemplified by being a certified B Corporation and collaborating with Harvard Business School and the International Foundation for Valuing Impacts (IFVI).
2018
Investor
Apr 2018
Groopit: The AI Problem-Solving Engine. Groopit combines real-time intelligence from employees to solve critical business problems that impact revenue, customer satisfaction, product, competition, operations, and more.
S
Investor
Mar 2018
Cell preservation today for the personalized therapies and diagnostics of tomorrow. Silene Biotech offers consumers affordable, accessible personalized cell preservation using protocols and standards meeting current Good Manufacturing Processes as established by the FDA.
Show all 11 entries ↓
Investment activity
2014–2021 · 6 investments
Recent (last 2 years)Earlier
